Home
 /
Papers
 /
Cell Biology
 /
Phosphorylated ubiquitin is a secondary messenger and an epigenetic mark mediating mitochondria to nucleus signaling
Preprint
Open access
Top 1% · Validated by QED

Phosphorylated ubiquitin is a secondary messenger and an epigenetic mark mediating mitochondria to nucleus signaling

Thomas J. Mercer, Bence Daniel, Craig Fredrickson +19 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.04.24.719390
99
%
QED Score
QED Impressions

By establishing that pS65Ub travels from damaged mitochondria to the nucleus as a secondary messenger and epigenetic mark that dismantles Polycomb silencing, this work overturns the isolation of mitochondrial quality control from chromatin-level gene regulation.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Phosphoserine 65 ubiquitin (pS65Ub), generated by PINK1 at damaged mitochondria, translocates to the nucleus where it is directly ligated to histone H2A at lysine 119 by PRC1, forming a novel epigenetic mark that reciprocally inhibits H2AK119 ubiquitination while potentiating deubiquitination, thereby driving polycomb target gene expression and accelerating dopaminergic neuron maturation, with nuclear pS65Ub accumulation observed in Parkinson's disease patient brains.

See full analysis
Main Claim 1 –

Mitochondrial pS65Ub Translocates and Accumulates in the Nucleus

Supporting evidence

  • PINK1-Dependent Nuclear pS65Ub Is Conjugated to Nuclear Substrates
  • Proteomics Identifies 879 Nuclear pS65Ub Substrates Across Pathways
  • Histone H2AK119 and H2BK120 Are Major pS65Ub Acceptors
  • Mitochondrial Damage Induces pS65Ub-Histone Formation Across Cell Types
  • Approximately 2% of Histone-Linked Ubiquitin Is pS65-Phosphorylated
Main Claim 2 –

pS65Ub Enriches at Repressed Developmental Gene Promoters

Supporting evidence

  • pS65Ub Targets Developmental Genes and Spares Most Mitochondrial Genes
  • pS65Ub-Promoter Genes Show H3K27me3 Enrichment and Low Accessibility
  • pS65Ub Chromatin Binding Overlaps Polycomb Components and TET2
  • pS65Ub Promoter Targeting Is Shared Between HeLa Cells and Neurons
Main Claim 3 –

Histone pS65 Ubiquitination Requires Mitochondrial Recruitment of PINK1

Supporting evidence

  • Histone pS65 Ubiquitination Occurs Within 15 Minutes of Depolarization
  • Artificial Mitochondrial PINK1 Recruitment Triggers Nuclear pS65Ub Signaling
  • Cleaved PINK1 Nuclear Localization Is Not Required for Nuclear pS65Ub
  • Parkin Shifts pS65Ub Toward Mitochondria and Away From Histones
  • PRKN-Mutant Patient Neurons Show Increased Nuclear pS65Ub Accumulation
  • PD Patient Fibroblasts With PINK1/PRKN Mutations Accumulate Nuclear pS65Ub
Main Claim 4 –

pS65Ub Is Noncanonically Ligated to Nuclear Substrates by E3s

Supporting evidence

  • PRC1/RING1 Mediates Most Histone pS65 Ubiquitination
  • RING1B-PCGF Complexes Ligate pS65Ub to Nucleosomes Less Efficiently

Abstract

Parkinson’s disease (PD) is commonly associated with dysfunctional mitochondrial homeostasis. PINK1, a S/T kinase mutated in early-onset PD, generates phosphoserine 65 ubiquitin (pS65Ub) on damaged mitochondria facilitating their removal. Here, we show that pS65Ub translocates into the nucleus after generation at damaged mitochondria and is directly attached to substrates by resident E3 ligases. Histone H2A is a major substrate and is modified at lysine 119 (H2AK119) by the polycomb silencer, E3 ligase RING1B. At nucleosomes, pS65Ub simultaneously suppresses RING1B and potentiates H2A deubiquitinases USP16 and USP21. Epigenetic profiling and RNA sequencing reveal that pS65Ub is enriched at the promoters of poorly expressed yet dynamically regulated genes and is associated with H2AK119ub depletion. Functionally, we show that pS65Ub enrichment drives polycomb target gene expression, which accelerates the maturation of dopaminergic neurons. Importantly, post-mortem PD brains exhibit elevated nuclear pS65Ub, potentially linking nuclear pS65Ub accumulation with disease pathogenesis. Together, these data indicate that pS65Ub generated at damaged mitochondria regulates fundamental cellular processes at distant sites.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?